RxSight
RXST | NASDAQ
$5.30
-$0.02 (-0.38%)
At close: Nov 16, 2026, 4:00 PM ET
$5.29
-$0.01 (-0.19%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.38%
(1D)No price chart data available for 1D timeframe.
Rating
32.5
Fundamentals Weak
Market Sentiment Bullish
Moat Narrow
Sector Rank #735/1021 (Top 72%)
Key Statistics
Market Data
Market Cap $222.22M
1D Range
5.18 5.43
52W Range
4.51 13.09
Valuation (TTM)
PE -4.14
PB 0.87
EV/EBITDA 0.42
Valuation (NTM)
Forward PE N/A
Forward PEG 0.17
Price Target $5.88
Cash Flow
FCF Yield 8.4%
SBC Adj. FCF Yield -5.5%
SBC Impact -165.5%
Margins
Gross Margin 76.1%
Operating Margin -50.4%
FCF Margin 15.3%
Growth (CAGR)
Revenue 3Y | 5Y 12.7% |
44.9%
Dil EPS 3Y | 5Y -22.6% |
22.3%
FCF 3Y | 5Y 220.1% |
64.0%
Returns
ROA -15.7%
ROE -20.1%
ROIC -23.0%
Financial Health
Net Cash
$244.36M
Current Ratio 4.20
Interest Coverage -4,389.50
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light...
Sector Healthcare
Industry Medical - Devices
Employees 461
IPO Date Jul 30, 2021
Website www.rxsight.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 3, 2026
EPS
-$0.39
Miss -27.18%
YoY:
-62.50% REV
$24.59M
Miss -9.59%
YoY:
-18.86%Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
8
Consensus
Hold
Price Target
$5.88
Upside
+10.94%
Buy (1)
Hold (6)
Sell (1)
Add to Watchlist
Select watchlists to add or remove RXST